The SLC12A5 gene helps brain cells keep the right chloride balance, which allows calming nerve signals to work as they should. The protein made by this gene helps your cells avoid becoming too excitable. If you carry a harmful variant in this gene, it can be linked to seizures, developmental delay, learning problems, and movement differences.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this topic, you can read more in the LearnHub.
Overview
SLC12A5Gene function
What if the gene works
The SLC12A5 gene helps nerve cells control chloride levels. This supports calming brain signals, so nerve networks can mature and work in a more balanced, controlled way.
Risk
What if the gene does not work
Changes in the SLC12A5 gene are linked to developmental and epileptic encephalopathy, often with early seizures and delayed development. Milder variants may cause fewer features, while more disruptive variants can bring earlier symptoms and greater impact.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the SLC12A5 gene, no treatment or drug choice approach tied specifically to this gene is currently established in clinical guidelines. The SLC12A5 gene is being studied as a drug target, with research exploring whether boosting KCC2 activity could help restore more balanced nerve signaling.
Conditions associated with SLC12A5
Gene function
What if the gene works
In the brain and spinal cord, the SLC12A5 gene helps nerve cells manage salts in a tightly controlled way. This keeps chloride levels low inside many mature neurons, which supports calm, well-timed signaling. Understanding how the SLC12A5 gene works can make it easier to see how your cells stay healthy over time.
The SLC12A5 gene helps move chloride out of many nerve cells along with potassium. This keeps the cell’s internal salt balance in the range needed for normal signaling.
Low chloride inside the cell lets GABA and glycine, two calming chemical messengers, slow nerve activity in the usual way. This is a central part of how the SLC12A5 gene supports calming signals in the brain.
By shaping how neurons respond to incoming messages, the SLC12A5 gene supports the balance between exciting and calming activity across brain and spinal cord networks. That balance helps processes like movement, sensation, and thinking stay coordinated.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SLC12A5 gene can weaken or destabilize the protein, reduce how much reaches the nerve cell surface, or lower its transport activity. In practical terms, how SLC12A5 variants affect brain signaling depends on the specific change: milder variants may leave some activity, while more severe variants can cause a near-complete loss of function. This difference can influence how early epilepsy and developmental features appear and how marked they become.
How variants are linked to conditions
Pathogenic variants in the SLC12A5 gene can cause developmental and epileptic encephalopathy, a rare condition marked by early seizures and developmental challenges. Some affected children are diagnosed with epilepsy of infancy with migrating focal seizures, one of the best described conditions linked to the SLC12A5 gene. When a clearly pathogenic SLC12A5 variant is found in the right clinical setting, it can confirm the genetic diagnosis rather than simply indicating higher risk.
A variant is not necessarily a diagnosis
Variation in genes is a normal feature of human biology and is widespread among people. Most genetic variants do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In other cases, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SLC12A5 gene. Risk is mainly shaped by whether someone carries a disease-causing change in this gene, and the effects can vary from one family to another.
Inheritance of SLC12A5 variants
For the best-known SLC12A5-related condition, inheritance is usually autosomal recessive. This means a child inherits one SLC12A5 gene variant from each parent, while parents who carry one variant are usually unaffected. If both parents are carriers, each pregnancy has a 25% chance of the child having the condition, a 50% chance of the child being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how SLC12A5 gene variants are inherited often depends on whether both parents carry a variant in this gene.
What does my SLC12A5 result mean for my family?
For SLC12A5, what it means for family members can depend on the exact condition and the specific gene change. Some SLC12A5-related conditions are inherited in a recessive way, so parents may be healthy carriers and brothers or sisters could also carry the change or be affected. Other reported SLC12A5 changes act in a dominant way, which can mean close relatives may also carry the variant. A genetics specialist can explain which pattern fits a specific result.
Genetic information
Genetic testing
How you find out about variants
SLC12A5 genetic testing looks for changes in the SLC12A5 gene using a blood sample or saliva sample. A lab reads the DNA sequence and compares it with the usual gene code, often through a multigene panel, exome sequencing, or genome sequencing, to identify variants that may help explain symptoms.
When should I consider getting a genetic test?
There isn't yet a broadly established, SLC12A5-specific reason for testing in most people. Testing may be considered with a doctor or genetic counselor as part of a broader evaluation for unexplained seizures, developmental differences, or a family history of similar brain-related conditions.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than another. This is common and can influence both how much benefit someone gets and how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies gene-drug patterns to help explain why the same treatment can work differently in different people. For many drugs, genes influence both how strongly a medicine acts and how the body processes it. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC12A5 gene
When should I seek medical advice?
There is not yet a broadly confirmed link between this gene and how people respond to medicines, so any concerns about side effects, a treatment not working as expected, or general health changes are best discussed with your doctor.
History
Researchers identified the SLC12A5 gene in the late 1990s while studying how nerve cells mature and communicate. From these first observations, research expanded steadily. Its discovery helped explain a major shift in neuroscience: why signaling in the developing brain does not work the same way as signaling in the mature brain. Over the following years, studies in animals and human tissue linked SLC12A5 to epilepsy, pain pathways, and neurodevelopmental conditions, making it an important gene in brain research. Although it is not a gene widely known in public culture, SLC12A5 has had a meaningful scientific impact because it reshaped how researchers think about inhibitory signaling in the nervous system.